Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (11-20 of 257) with videos related to

Pageof 26
Sort By:
Current Opinion in Hematology|July 7, 2011
Recent advances in heparin-induced thrombocytopeniaAdam Cuker
American Journal of Hematology|March 26, 2018
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practicesAdam Cuker
Seminars in Thrombosis and Hemostasis|September 29, 2022
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate IllnessAdam Cuker
Seminars in Thrombosis and Hemostasis|February 9, 2012
Current and emerging therapeutics for heparin-induced thrombocytopeniaAdam Cuker
Seminars in Hematology|July 13, 2010
Toxicities of the thrombopoietic growth factorsAdam Cuker
Seminars in Thrombosis and Hemostasis|June 22, 2012
Unfractionated heparin for the treatment of venous thromboembolism: best practices and areas of uncertaintyAdam Cuker
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Update in the diagnosis and management of heparin-induced thrombocytopeniaAdam Cuker
Journal of Thrombosis and Thrombolysis|September 21, 2015
Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indicationAdam Cuker
Seminars in Thrombosis and Hemostasis|June 24, 2017
Clinical Scoring Systems in Thrombosis and HemostasisAdam Cuker
Translational Research : the Journal of Laboratory and Clinical Medicine|May 21, 2020
Development and use of clinical practice guidelines on venous thromboembolismAdam Cuker
Pageof 26

Showing results (11-20 of 257) with videos related to

Sort By:
Pageof 26
Current Opinion in Hematology|July 7, 2011
Recent advances in heparin-induced thrombocytopeniaAdam Cuker
American Journal of Hematology|March 26, 2018
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practicesAdam Cuker
Seminars in Thrombosis and Hemostasis|September 29, 2022
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate IllnessAdam Cuker
Seminars in Thrombosis and Hemostasis|February 9, 2012
Current and emerging therapeutics for heparin-induced thrombocytopeniaAdam Cuker
Seminars in Hematology|July 13, 2010
Toxicities of the thrombopoietic growth factorsAdam Cuker
Seminars in Thrombosis and Hemostasis|June 22, 2012
Unfractionated heparin for the treatment of venous thromboembolism: best practices and areas of uncertaintyAdam Cuker
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Update in the diagnosis and management of heparin-induced thrombocytopeniaAdam Cuker
Journal of Thrombosis and Thrombolysis|September 21, 2015
Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indicationAdam Cuker
Seminars in Thrombosis and Hemostasis|June 24, 2017
Clinical Scoring Systems in Thrombosis and HemostasisAdam Cuker
Translational Research : the Journal of Laboratory and Clinical Medicine|May 21, 2020
Development and use of clinical practice guidelines on venous thromboembolismAdam Cuker
Pageof 26